The trial that could transform care for people with blood disorders such as sickle cell and rare blood types.
In what can be called a breakthrough in medical science, red blood cells grown in a laboratory have been transfused into volunteers in a world-first clinical trial.
What are you working on next?
Rosendo: Our next steps…will be on the development of the manipulability of this robot. More specifically, we have been asking ourselves the question: “Now that we can stand up, what can we do that other robots cannot?”, and we already have some preliminary results on climbing to places that are higher than the center of gravity of the robot itself. After mechanical changes on the forelimbs, we will better evaluate complex handling that might require both hands at the same time, which is rare in current mobile robots.
Multi-Modal Legged Locomotion Framework with Automated Residual Reinforcement Learning, by Chen Yu and Andre Rosendo from ShanghaiTech University, was presented this week at IROS 2022 in Kyoto, Japan. More details are available on Github.
“We grow them in huge bioreactors in just three weeks — while regular cannabis takes 14 to 23 weeks,” Sobel said. “Our tech can also significantly increase the levels of active ingredients, as a percent of the weight, versus what is found normally in the plant.”
An Israeli company has cloned hemp cells and used a bioreactor to grow them into a substance with all the active compounds of cannabis — and 12 times the potency.
BioHarvest Sciences says the breakthrough could make the medical benefits of cannabis available in cheaper, cleaner and greener form. It has started applying for the necessary licenses to manufacture and sell its product for medical use in Israel and the United States.
KanawatTH/iStock.
Researchers at the University of Toronto are combining artificial intelligence and microelectronics to create innovative technology that is safe and effective. The research team wants to incorporate neural implants into miniature silicone chips in a similar way that is done to manufacture chips used in today’s computers.
A critical new pathway to treating an aggressive brain tumor might be found in the complex diversity within the tumor tissue, according to a new paper by scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI).
The CDI laboratory deeply analyzed tumor tissue using an advanced mass spectrometry with special focus on lipids, a class of molecules that includes fats, according to the new paper, in the journal Scientific Reports.
“Lipid ions presented here lay the foundation for future studies that are required to understand their interconnecting signaling pathways in relation to cell function, tumor progression, and resistance to therapy,” according to the paper. “Understanding their functional relevance is essential for the identification of new therapeutics based on lipid pathway targets.”
Technology is advancing so rapidly that it’s almost impossible to keep up with the ever-changing landscape of innovation. That’s why we’ve compiled the 50 most insane new scientific discoveries of the last decade into one epic video!
🔔 SUBSCRIBE TO THE INFOGRAPHICS SHOW ►
Continue reading “50 UNBELIEVABLE Scientific Discoveries Of The Decade” »
Artificial Intelligence Latest News Tech news
The advancements of AI in bringing back your dead loved.
John J. Collins is Holmes Professor of Old Testament Criticism and Interpretation at Yale Divinity School and has served as president of both the Society of Biblical Literature and Catholic Biblical Association. His many other books include “Apocalypse, Prophecy, and Pseudepigraphy; Beyond the Qumran Community; and The Eerdmans Dictionary of Early Judaism.
Apocalyptic literature evokes an imaginative world that is set in deliberate counterpoint to the experiential world of the present. Apocalypticism thrives especially in times of crisis, and it functions by offering a resolution of the relevant crisis, not in practical terms but in terms of imagination and faith.
Continue reading “The Invention of The Exodus Story — Dr. John J. Collins” »
When in 2015, Eileen Brown looked at the ETER9 Project (crazy for many, visionary for few) and wrote an interesting article for ZDNET with the title “New social network ETER9 brings AI to your interactions”, it ensured a worldwide projection of something the world was not expecting.
Someone, in a lost world (outside the United States), was risking, with everything he had in his possession (very little or less than nothing), a vision worthy of the American dream. At that time, Facebook was already beginning to annoy the cleaner minds that were looking for a difference and a more innovative world.
Today, after that test bench, we see that Facebook (Meta or whatever) is nothing but an illusion, or, I dare say, a big disappointment. No, no, no! I am not now bad-mouthing Facebook just because I have a project in hand that is seen as a potential competitor.
I was even a big fan of the “original” Facebook; but then I realized, it took me a few years, that Mark Zuckerberg is nothing more than a simple kid, now a man, who against everything and everyone, gave in to whims. Of him, initially, and now, perforce, of what his big investors, deluded by himself, of what his “metaverse” would be.
Adobe wants to show the world that AI can do more for designers than generate frightening JPEGs.
AI-powered, generative image search engines, like DALL-E and Stable Diffusion, have stolen the hearts of AI enthusiasts since their release. Some even warned this may be the death of Photoshop, Adobe’s signature imaging software.
But after viewing Adobe’s latest innovations at the MAX Conference in Los Angeles this week, the company is taking a different approach with AI.
